Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Bio-Rad Laboratories (NY: BIO)
458.36 USD  +3.93 (+0.86%)
Official Closing Price  /  Updated: 7:00 PM EDT, Jul 2, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 167,100
Open 456.18
Bid (Size) 426.94 (1)
Ask (Size) 4294.67 (1)
Prev. Close 454.43
Today's Range 455.53 - 463.56
52wk Range 303.82 - 497.42
Shares Outstanding 24,701,407
Dividend Yield N/A
Performance
YTD
+23.16%
+23.16%
1 Month
-2.63%
-2.63%
3 Month
+25.31%
+25.31%
6 Month
+24.97%
+24.97%
1 Year
+46.29%
+46.29%
Top News
More News
Analysts Expect IHI Will Reach $288
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... Read More
category ETFs
from ETF Channel
Moderna, Other Vaccine Developers Lead The Way In New GERM ETF
Vaccines are all the rage these days, both in the medical and investment fields. Now, there's an exchange-traded fund for ... Read More
category Sector ETFs , Top Stories , Biotech , and 10 more.
from Benzinga
More News
Read More
FXH, NVST, DXCM, BIO: ETF Outflow Alert
category ETFs
from ETF Channel
RPT-Outbreak quashed, China launches test lab spending spree
category companyNews
from Reuters: Company News
Biodesix Collaborates With Bio-Rad to Launch a Serology Test to Detect Coronavirus (COVID-19) Antibodies
from Business Wire News Releases
Outbreak quashed, China launches test lab spending spree
category companyNews
from Reuters: Company News
Bio-Rad Laboratories Larger Than S&P 500 Component Baker Hughes
category Stocks
from Market News Video
FDA Evaluates 5 More COVID-19 Antibody Tests
category PKI , ABT , Market News , and 1 more.
from Motley Fool
S&P Dow Jones Indices Announces Tyler Technologies, Bio-Rad Laboratories and Teledyne Technologies Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
from PR Newswire
Takeda says coronavirus treatment trial using recovered patients' blood could start in July
category companyNews
from Reuters: Company News
The Daily Biotech Pulse: Regulatory Delay For Novartis' Multiple Sclerosis Drug, FSD Gets Nod For COVID-19 Study
category XGN , ARNA , FDA , and 43 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.